Vista Pharmaceuticals share news and announcements

BSE: 524711Pharmaceuticals & BiotechnologySmall Cap

₹5.84₹0.36 (6.57%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹5.48.

52-week range of traded prices to 23 Oct 2026

₹5.32Low, 16 Sep 2026₹10.50High, 23 Oct 2025

Market cap: ₹36 Cr3,508th largest listed
P/E: Lossover the last 12 months
P/B: 1.0
Dividend yield: Nonein the last 12 months
ROE: −28.7%
ROCE: −32.5%
Debt to equity: 0.27
Volume, BSE: 6,933

Vista Pharmaceuticals share news and announcements

532 announcements, routine notices left out, newest first. Page 2 of 11.

Nov 2024
- 7 Nov · Board meeting
  Meeting on 13 Nov 2024: quarterly results
- 7 Nov · Board meeting
  VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 ,inter alia, to consider and approve 1. Un Audited financial .... (opens in a new tab)
Sep 2024
- 30 Sep · Meeting
  Scrutinizer Report (opens in a new tab)
- 30 Sep · Meeting
  AGM Outcome (opens in a new tab)
- 8 Sep · Meeting
  Intimation of Book Closure regarding 33rd Annual General Meeting of Company (opens in a new tab)
- 8 Sep · Meeting
  Submission of 33rd AGM Notice of the company (opens in a new tab)
Aug 2024
- 14 Aug · Business
  NIL Statement (opens in a new tab)
- 13 Aug · Board meeting
  Financial results fro the quarter ended 30.06.2024 (opens in a new tab)
- 5 Aug · Board meeting
  Meeting on 13 Aug 2024: quarterly results
- 3 Aug · Board meeting
  VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 ,inter alia, to consider and approve 1. Un Audited financial .... (opens in a new tab)
Jun 2024
- 14 Jun · Announcement under Regulation 30 (LODR)-Allotment
  Circular Resolution (opens in a new tab)
May 2024
- 28 May · Board meeting
  Board Meeting outcome (opens in a new tab)
- 21 May · Board meeting
  Meeting on 28 May 2024: audited results
- 21 May · Board meeting
  VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2024 ,inter alia, to consider and approve 1. Audited financial .... (opens in a new tab)
Apr 2024
- 30 Apr · Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
  Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars .... (opens in a new tab)
- 30 Apr · Compliance Under Regulation 7(3) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015
  Compliance Certificate (opens in a new tab)
- 30 Apr · Compliance As Per Regulation 40 (10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended 31.03.2024
  PCS Certificate (opens in a new tab)
Feb 2024
- 13 Feb · Outcome Of Circular Resolutions Passed By Board Of Directors Of The Company By Circulation On 13.02.2024 Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
  Circular resolution (opens in a new tab)
- 10 Feb · Management
  Company Secretary Appointment disclosure (opens in a new tab)
- 10 Feb · Board meeting
  Board Meeting Outcome (opens in a new tab)
- 2 Feb · Board meeting
  Meeting on 10 Feb 2024: quarterly results
- 2 Feb · Board meeting
  VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2024 ,inter alia, to consider and approve 1. Un-Audited financial .... (opens in a new tab)
Jan 2024
- 29 Jan · Outcome Of Circular Resolutions Passed By Board Of Directors Of The Company By Circulation On 29.01.2024 Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
  Circular resolution (opens in a new tab)
- 8 Jan · Announcement under Regulation 30 (LODR)-Allotment
  Kindly note the allotment of 2,66,667 equity shares pursuant to the conversion of 2,66,667 warrants issued to others on a private placement (opens in a new tab)
Dec 2023
- 30 Dec · Announcement under Regulation 30 (LODR)-Allotment
  Kindly note the allotment of 5,33,333 equity shares pursuant to the conversion of 5,33,333 warrants issued to others on a private placement (opens in a new tab)
- 6 Dec · Announcement under Regulation 30 (LODR)-Allotment
  Kindly note the allotment of 2,00,000 equity shares pursuant to the conversion of 2,00,000 warrants issued to others on a private placement (opens in a new tab)
Nov 2023
- 28 Nov · Announcement under Regulation 30 (LODR)-Allotment
  Kindly take note of the allotment of 6,40,000 equity shares pursuant to the conversion of 6,40,000 warrants issued to others on a private placement basis (opens in a new tab)
- 10 Nov · Results
  Copy of unaudited Financial Results for the quarter and half year ended 30.09.2023 along with Limited Review Report is enclosed herewith (opens in a new tab)
- 10 Nov · Board meeting
  It is hereby informed that the Meeting of the Board of Directors of the Company was held on Friday, 10th November 2023.at 04:00 PM and ended at 05:55 PM at the corporate office of the Company. (opens in a new tab)
- 7 Nov · Announcement under Regulation 30 (LODR)-Allotment
  Kindly take note of the Allotment of 4,00,000 Equity shares pursuant to the conversion of 4,00,000 warrants issued to others on a private placement basis. (opens in a new tab)
- 3 Nov · Board meeting
  Meeting on 10 Nov 2023: quarterly results
- 3 Nov · Board meeting
  VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 ,inter alia, to consider and approve The meeting of the Board .... (opens in a new tab)
Oct 2023
- 20 Oct · Announcement under Regulation 30 (LODR)-Allotment
  Kindly take note of the Allotment of 3,33,333 Equity Shares pursuant to the conversion of 3,33,333 convertible warrants issued to others on a preferential Basis. (opens in a new tab)
- 16 Oct · Management
  This is to inform you that the Board at its meeting held on 16th October 2023 has appointed the following Directors in an Independent capacity. (opens in a new tab)
- 16 Oct · Announcement under Regulation 30 (LODR)-Allotment
  Kindly take note of the Allotment of 4,66,667 equity shares pursuant to the conversion of 4,66,667 warrants issued to others on preferential basis. (opens in a new tab)
- 9 Oct · Announcement under Regulation 30 (LODR)-Allotment
  Kindly take note of allotment of 1,33,333 equity shares on conversion of 1,33,333 warrants issued to others on preferential basis. (opens in a new tab)
- 3 Oct · Meeting
  Scrutinizer report along with the voting results for the 29th Annual General Meeting of the Company held on 30th September 2023 through OVAM (opens in a new tab)
Sep 2023
- 30 Sep · Meeting
  Outcome of 32nd Annual General Meeting of the Company which was held on the 30th Day of September 2023 at 11:00 AM through mode. (opens in a new tab)
- 27 Sep · Meeting
  This corrigendum is issued in connection with the Annual General Meeting notice dated 06.09.2023 and should be read in conjunction with the original notice 06.09.2023 (opens in a new tab)
- 20 Sep · Announcement under Regulation 30 (LODR)-Allotment
  Kindly take note of the allotment of 5,00,000 equity shares on conversion of 5,00,000 warrants issued to others on a preferential basis. (opens in a new tab)
- 7 Sep · Meeting
  Intimation of 32nd Annual General Meeting (opens in a new tab)
- 6 Sep · Board meeting
  Outcome of Board Meeting- Regulation 30 (opens in a new tab)
- 1 Sep · Board meeting
  Meeting on 6 Sep 2023: annual general meeting, preferential issue of shares and increase in authorised capital
- 1 Sep · Board meeting
  VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/09/2023 ,inter alia, to consider and approve 1. To revise notice, .... (opens in a new tab)
- 1 Sep · Results
  Board of Directors of the Company at its Meeting held on Saturday 12th August 2023 at 4.00 P.M at the Corporate office of the Company has considered and approved the unaudited financials .... (opens in a new tab)
Aug 2023
- 26 Aug · Announcement under Regulation 30 (LODR)-Allotment
  Kindly take note of the allotment of 5,52,821 equity shares on conversion of 5,52,821 warrants to others on a preferential basis. (opens in a new tab)
- 12 Aug · Results
  Financial Results for the Quarter ended 30th June 2023 (opens in a new tab)
- 12 Aug · Results
  It is hereby informed that the Board of Directors of the Company at its Meeting held on Saturday, 12th August 2023.at 04:00 PM and ended at 4:55 P.M at the corporate office of the Company .... (opens in a new tab)
- 7 Aug · Board meeting
  Meeting on 12 Aug 2023: quarterly results
- 5 Aug · Board meeting
  VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2023 ,inter alia, to consider and approve 1. To consider, approve .... (opens in a new tab)

Vista Pharmaceuticals share news and announcements

Nov 2024

Sep 2024

Aug 2024

Jun 2024

May 2024

Apr 2024

Feb 2024

Jan 2024

Dec 2023

Nov 2023

Oct 2023

Sep 2023

Aug 2023